Barriers to insulin initiation: The translating research into action for diabetes insulin starts project

Diabetes Care

Volumn 33, Issue 4, 2010, Pages 733-735

  Karter, Andrew J ^a,b   Subramanian, Usha ^c   Saha, Chandan ^c   Crosson, Jesse C ^d   Parker, Melissa M ^a   Swain, Bix E ^a   Moffet, Howard H ^a   Marrero, David G ^c  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHOBIA; PRESCRIPTION; SELF CARE; SELF INJECTION; SOCIAL ASPECT;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MEDICATION ADHERENCE;

EID: 77953044294     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-1184     Document Type: Article

References (16)

1. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29: 1963-1972 (Pubitemid 44156663)
2. Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 2007;357:1716-1730
3. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999;281: 2005-2012
4. Brunton SA, Davis SN, Renda SM. Overcoming psychological barriers to insulin use in type 2 diabetes. Clin Cornerstone 2006;8(Suppl. 2):S19-S26 (Pubitemid 44283560)
5. Karter AJ, Parker MM, Moffet HH, Ahmed AT, Schmittdiel JA, Selby JV. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Services Research 2009;44:1640-1661
6. Leslie CA, Satin-Rapaport W. Psychological insulin resistance: a challenge for diabetes patients and health care professionals. J New Developments Clin Med 1995;13: 21-27
7. TRIAD Study Group. The Translating Research Into Action for Diabetes (TRIAD) Study: a multicenter study of diabetes in managed care. Diabetes Care 2002;25: 386-389
8. Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med 2004;36: 588-594
9. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study: primary care evaluation of mental disorders: patient health questionnaire. JAMA 1999;282:1737-1744
10. The American Association for Public Opinion Research. 2008. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 5th ed. Lenexa, Kansas
11. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005;28:2543-2545
12. Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E, Nathan DM. Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ 2008;34:511-517
13. Schillinger D, Piette J, Grumbach K, Wang F, Wilson C, Daher C, Leong-Grotz K, Castro C, Bindman AB. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med 2003; 163:83-90
14. Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, Campbell R. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005;61:133-155
15. Huang ES, Brown SE, Thakur N, Carlisle L, Foley E, Ewigman B, Meltzer DO. Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care 2009;32:311-316
16. Polonsky W. Psychological insulin resistance: the patient perspective. Diabetes Educ 2007;33(Suppl. 7):241S-244S